ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,926 | -9.8% | 9,350 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $186,152 | -12.5% | 9,152 | -6.4% | 0.00% | 0.0% |
| Q1 2023 | $212,813 | -28.4% | 9,780 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $297,039 | +21.2% | 9,585 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $245,000 | +26.9% | 9,620 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $193,000 | -18.6% | 9,485 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | -33.4% | 9,573 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $356,000 | +24.5% | 10,246 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $286,000 | +2.1% | 10,553 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $280,000 | +4.1% | 10,804 | -13.4% | 0.00% | 0.0% |
| Q1 2021 | $269,000 | +0.4% | 12,479 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $268,000 | +41.8% | 12,445 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $189,000 | -35.5% | 12,803 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | +42.9% | 13,094 | -10.0% | 0.00% | 0.0% |
| Q1 2020 | $205,000 | -18.0% | 14,543 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $250,000 | -54.0% | 15,383 | -0.8% | 0.00% | -50.0% |
| Q3 2019 | $543,000 | -38.4% | 15,512 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $881,000 | -10.5% | 15,621 | +16.0% | 0.00% | -25.0% |
| Q1 2019 | $984,000 | +10.9% | 13,469 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $887,000 | -29.4% | 13,906 | +10.4% | 0.00% | 0.0% |
| Q3 2018 | $1,256,000 | +46.2% | 12,591 | +4.2% | 0.00% | +33.3% |
| Q2 2018 | $859,000 | -27.7% | 12,086 | +5.9% | 0.00% | -25.0% |
| Q1 2018 | $1,188,000 | -1.9% | 11,411 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $1,211,000 | +334.1% | 12,025 | +50.8% | 0.00% | +300.0% |
| Q3 2017 | $279,000 | +253.2% | 7,972 | +140.5% | 0.00% | – |
| Q2 2017 | $79,000 | – | 3,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |